Similarly, the efficacy of modified Jinshui Liujian decoction combined with Bajitian pill in COPD rats correlates with elevated Nrf2/HO-1 levels and reduced oxidative markers like malondialdehyde (MDA) [64]. Here, HMOX1 is linked to chronic obstructive pulmonary disease.